You just read:

eTheRNA Completes Enrolment of Low Dose Cohort for Phase 1b Study of TriMix mRNA-based Cancer Specific Immunotherapy (ECI-006) in Melanoma

News provided by

eTheRNA

19 Mar, 2018, 07:00 GMT